Heartflow, Inc.
HTFL Healthcare Health Information Services
Heartflow, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $176.0 million, up 39.9% from fiscal 2024.
- Revenue
- +47.6%
- EPS
- +87.7%
- Free cash flow
- +62.6%
Quarter to June 2026, against a year earlier
Follow HTFL
Alert me
Heartflow, Inc. (HTFL) P/S ratio
As of 5 November 2026, Heartflow, Inc. (HTFL) trades at a P/S ratio of 21.3×. Over the past ten years it has ranged from 1.2× (August 2025) to 24.7× (October 2026); the current reading is higher than 96% of that period. That is above the Health Information Services industry median of 1.8× and above the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 6.1× | 399.20% |
| FY2024 | 1.2× | 0.00% |
| FY2023 | 1.2× | — |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Jun 2026 | 12.0× | 9.81% |
| Mar 2026 | 10.9× | 78.37% |
| Dec 2025 | 6.1× | (40.23%) |
| Sep 2025 | 10.2× | 735.23% |
| 6 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| TDOC Teladoc Health, Inc. compare | 0.7× |
| PRVA Privia Health Group, Inc. compare | 1.2× |
| OMCL Omnicell, Inc. compare | 1.4× |
| WAY Waystar Holding Corp. compare | 4.4× |
| HQY HealthEquity, Inc. compare | 6.3× |
| SDGR Schrodinger, Inc. compare | 8.1× |
| DOCS Doximity, Inc. compare | 9.0× |
| HNGE Hinge Health Inc. compare | 12.7× |
| HTFL Heartflow, Inc. | 21.3× |
| Health Information Services industry median | 1.8× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on HTFL
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- The full statement